Perlecan inhibits autophagy to maintain muscle homeostasis in mouse soleus muscle

Matrix Biology

Volumn 48, Issue , 2015, Pages 26-35

  Ning, Liang ^a   Xu, Zhuo ^a   Furuya, Norihiko ^a   Nonaka, Risa ^a   Yamada, Yoshihiko ^b   Arikawa Hirasawa, Eri ^a  

^a JUNTENDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Autophagy; Mechanical stress; Muscle atrophy; Perlecan; Soleus muscle

Indexed keywords

ADENYLATE KINASE; COLLAGEN TYPE 6; DECORIN; ENDOSTATIN; LAMININ; MAMMALIAN TARGET OF RAPAMYCIN; PERLECAN; PROTEIN KINASE B; PROTEIN P62; PROTEIN P70; AMPK ALPHA1 SUBUNIT, MOUSE; COL2A1 PROTEIN, MOUSE; COLLAGEN TYPE 2; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; MAP1LC3 PROTEIN, MOUSE; MECHANISTIC TARGET OF RAPAMYCIN COMPLEX 1; MICROTUBULE ASSOCIATED PROTEIN; MULTIPROTEIN COMPLEX; PROTEOHEPARAN SULFATE; S6 KINASE; TARGET OF RAPAMYCIN KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGOSOME; AUTOPHAGY; CONTROLLED STUDY; HOMEOSTASIS; LYSOSOME; MOUSE; MUSCLE ATROPHY; MUSCLE TWITCH; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SOLEUS MUSCLE; TRANSGENE; ANIMAL; C57BL MOUSE; DEFICIENCY; FAST MUSCLE FIBER; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PHOSPHORYLATION; REPORTER GENE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TENOTOMY; TRANSGENIC MOUSE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AUTOPHAGY; COLLAGEN TYPE II; GENE EXPRESSION REGULATION; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HEPARAN SULFATE PROTEOGLYCANS; HOMEOSTASIS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROTUBULE-ASSOCIATED PROTEINS; MULTIPROTEIN COMPLEXES; MUSCLE FIBERS, FAST-TWITCH; MUSCLE, SKELETAL; MUSCULAR ATROPHY; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT FUSION PROTEINS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; TENOTOMY; TOR SERINE-THREONINE KINASES;

EID: 84947870176     PISSN: 0945053X     EISSN: 15691802     Source Type: Journal    
DOI: 10.1016/j.matbio.2015.08.002     Document Type: Article

References (42)

1. Ruegg M.A., Glass D.J. Molecular mechanisms and treatment options for muscle wasting diseases. Annu. Rev. Pharmacol. Toxicol. 2011, 51:373-395.
2. Bialek P., Morris C., Parkington J., et al. Distinct protein degradation profiles are induced by different disuse models of skeletal muscle atrophy. Physiol. Genomics 2011, 43:1075-1086.
3. Furuya N., Ikeda S.I., Sato S., et al. PARK2/parkin-mediated mitochondrial clearance contributes to proteasome activation during slow-twitch muscle atrophy via NFE2L1 nuclear translocation. Autophagy 2014, 10.
4. Arikawa-Hirasawa E., Watanabe H., Takami H., et al. Perlecan is essential for cartilage and cephalic development. Nat. Genet. 1999, 23:354-358.
5. Arikawa-Hirasawa E., Yamada Y. Roles of perlecan in development and disease: studies in knockout mice and human disorders. Seikagaku J. Jpn. Biochem. Soc. 2001, 73:1257-1261.
6. Arikawa-Hirasawa E., Rossi S.G., Rotundo R.L., et al. Absence of acetylcholinesterase at the neuromuscular junctions of perlecan-null mice. Nat. Neurosci. 2002, 5:119-123.
7. Iozzo R.V., Schaefer L. Proteoglycan form and function: a comprehensive nomenclature of proteoglycans. Matrix Biol. 2015, 42:11-55.
8. Nonaka R., Iesaki T., de Vega S., et al. Perlecan deficiency causes endothelial dysfunction by reducing the expression of endothelial nitric oxide synthase. Phys. Rep. 2015, 3.
9. Fuki I.V., Iozzo R.V., Williams K.J. Perlecan heparan sulfate proteoglycan: a novel receptor that mediates a distinct pathway for ligand catabolism. J Biol Chem 2000, 275:25742-25750.
10. Lord M.S., Chuang C.Y., Melrose J., et al. The role of vascular-derived perlecan in modulating cell adhesion, proliferation and growth factor signaling. Matrix Biol. 2014, 35:112-122.
11. Schaefer L. Proteoglycans, key regulators of cell-matrix dynamics. Matrix Biol. 2014, 35:1-2.
12. Kerever A., Mercier F., Nonaka R., et al. Perlecan is required for FGF-2 signaling in the neural stem cell niche. Stem Cell Res. 2014, 12:492-505.
13. Xu Z., Ichikawa N., Kosaki K., et al. Perlecan deficiency causes muscle hypertrophy, a decrease in myostatin expression, and changes in muscle fiber composition. Matrix Biol. 2010, 29:461-470.
14. Carlson C.J., Booth F.W., Gordon S.E. Skeletal muscle myostatin mRNA expression is fiber-type specific and increases during hindlimb unloading. Am. J. Physiol 1999, 277:R601-R606.
15. Lin N.Y., Beyer C., Giessl A., et al. Autophagy regulates TNFalpha-mediated joint destruction in experimental arthritis. Ann. Rheum. Dis. 2013, 72:761-768.
16. Choi A.M., Ryter S.W., Levine B. Autophagy in human health and disease. N. Engl. J. Med. 2013, 368:1845-1846.
17. Mizushima N., Yoshimori T., Levine B. Methods in mammalian autophagy research. Cell 2010, 140:313-326.
18. Rubinsztein D.C., Codogno P., Levine B. Autophagy modulation as a potential therapeutic target for diverse diseases. Nat. Rev. Drug Discov. 2012, 11:709-730.
19. Neill T., Schaefer L., Iozzo R.V. Instructive roles of extracellular matrix on autophagy. Am. J. Pathol. 2014, 184:2146-2153.
20. Grumati P., Coletto L., Sabatelli P., et al. Autophagy is defective in collagen VI muscular dystrophies, and its reactivation rescues myofiber degeneration. Nat. Med. 2010, 16:1313-1320.
21. Carmignac V., Svensson M., Korner Z., et al. Autophagy is increased in laminin alpha2 chain-deficient muscle and its inhibition improves muscle morphology in a mouse model of MDC1A. Hum. Mol. Genet. 2011, 20:4891-4902.
22. Bix G., Fu J., Gonzalez E.M., et al. Endorepellin causes endothelial cell disassembly of actin cytoskeleton and focal adhesions through alpha2beta1 integrin. J Cell Biol. 2004, 166:97-109.
23. Poluzzi C., Casulli J., Goyal A., et al. Endorepellin evokes autophagy in endothelial cells. J Biol Chem. 2014, 289:16114-16128.
24. Ishijima M., Suzuki N., Hozumi K., et al. Perlecan modulates VEGF signaling and is essential for vascularization in endochondral bone formation. Matrix Biol. 2012, 31:234-245.
25. Tsumaki N., Tanaka K., Arikawa-Hirasawa E., et al. Role of CDMP-1 in skeletal morphogenesis: promotion of mesenchymal cell recruitment and chondrocyte differentiation. Eur. J. Cell Biol. 1999, 144:161-173.
26. Mammucari C., Milan G., Romanello V., et al. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab. 2007, 6:458-471.
27. Wohlgemuth S.E., Seo A.Y., Marzetti E., et al. Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp. Gerontol. 2010, 45:138-148.
28. Mizushima N., Yamamoto A., Matsui M., et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol. Biol. Cell 2004, 15:1101-1111.
29. Kabeya Y., Mizushima N., Ueno T., et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 2000, 19:5720-5728.
30. Komatsu M., Waguri S., Koike M., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131:1149-1163.
31. Alers S., Loffler A.S., Wesselborg S., et al. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol. Cell. Biol. 2012, 32:2-11.
32. Chiang G.G., Abraham R.T. Phosphorylation of mammalian target of rapamycin (mTOR) at Ser-2448 is mediated by p70S6 kinase. J. Biol. Chem. 2005, 280:25485-25490.
33. Parrales A., Lopez E., Lee-Rivera I., et al. ERK1/2-dependent activation of mTOR/mTORC1/p70S6K regulates thrombin-induced RPE cell proliferation. Cell. Signal. 2013, 25:829-838.
34. Inoki K., Li Y., Xu T., et al. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003, 17:1829-1834.
35. Inoki K., Zhu T., Guan K.L. TSC2 mediates cellular energy response to control cell growth and survival. Cell 2003, 115:577-590.
36. Mendoza M.C., Er E.E., Blenis J. The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation. Trends Biochem. Sci. 2011, 36:320-328.
37. Schiaffino S., Dyar K.A., Ciciliot S., et al. Mechanisms regulating skeletal muscle growth and atrophy. FEBS J. 2013, 280:4294-4314.
38. Mitch W.E., Goldberg A.L. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N. Engl. J. Med. 1996, 335:1897-1905.
39. Kondo H., Miura M., Itokawa Y. Oxidative stress in skeletal muscle atrophied by immobilization. Acta Physiol. Scand. 1991, 142:527-528.
40. Lawler J.M., Song W., Demaree S.R. Hindlimb unloading increases oxidative stress and disrupts antioxidant capacity in skeletal muscle. Free Radic. Biol. Med. 2003, 35:9-16.
41. Costell M., Gustafsson E., Aszodi A., et al. Perlecan maintains the integrity of cartilage and some basement membranes. J Cell Biol. 1999, 147:1109-1122.
42. Sciorati C., Galvez B.G., Brunelli S., et al. Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy. J. Cell Sci. 2006, 119:5114-5123.